Carboxylic acids and derivatives
Medchemexpress LLC Citrate synthase | 9027-96-7 | ~98 KDa dimer (49 KDa monomer) | 500 U
Citrate synthase catalyzes the initial reaction of the citric acid cycle, condensing acetyl-CoA and oxaloacetate to form citrate. This enzyme is primarily localized within the mitochondrial matrix of eukaryotic cells. Each unit of the enzyme is defined by its ability to form 1.0 μmole of citrate from oxalacetate and acetyl CoA per minute at pH 8.0 at 37°C.
- Catalyzes key reaction in citric acid cycle
- Localized in mitochondrial matrix
- Biochemical reagent
- Metabolic enzyme/protease
- Endogenous metabolite
[C@H](NC(=O)OCc1ccccc1)C(O)=O | 5g | 633664835](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502427985.JPG-250.jpg)
eMolecules 3160-59-6 | Cbz-Ile-OH | Ambeed | MFCD00027064 | 265.309 | C14H19NO4 | 98.000 | CC[C@H](C)[C@H](NC(=O)OCc1ccccc1)C(O)=O | 5g | 633664835
Cbz-Ile-OH | Ambeed | 3160-59-6 | MFCD00027064 | 265.309 | C14H19NO4 | 98.000 | CC[C@H](C)[C@H](NC(=O)OCc1ccccc1)C(O)=O | 5g | 633664835
Medchemexpress LLC AZD9496 maleate | 1639042-28-6 | 99.4% | 50 MG
AZD9496 maleate is a potent and selective estrogen receptor (ERα) antagonist with an IC50 of 0.28 nM. It functions as an orally bioavailable selective estrogen receptor degrader (SERD), identified as a laboratory chemical.
- Potent and selective estrogen receptor (ERα) antagonist
- Orally bioavailable selective estrogen receptor degrader (SERD)
- Suitable for scientific research
- Used in signaling pathways
- For research use only
OCC1c2ccccc2-c2ccccc12)C(=O)OCC1c2ccccc2-c2ccccc12 | 250mg | 600847098](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502420355.PNG-250.jpg)
eMolecules 187671-16-5 | Fmoc-Asp-OFm | Ambeed | MFCD00237653 | 533.580 | C33H27NO6 | 98.000 | OC(=O)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc12)C(=O)OCC1c2ccccc2-c2ccccc12 | 250mg | 600847098
Fmoc-Asp-OFm | Ambeed | 187671-16-5 | MFCD00237653 | 533.580 | C33H27NO6 | 98.000 | OC(=O)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc12)C(=O)OCC1c2ccccc2-c2ccccc12 | 250mg | 600847098
Medchemexpress LLC HY-15871 1mg Medchemexpress, GGTI298 (Trifluoroacetate) CAS:1217457-86-7 Purity:>98%
Medchemexpress, HY-15871 1mg GGTI298 (Trifluoroacetate) CAS:1217457-86-7 GGTI298 Trifluoroacetate is a CAAZ peptidomimetic geranylgeranyltransferase I (GGTase I) inhibitor, which can inhibit Rap1A with IC50 of 3 μM; little effect on Ha-Ras with IC50 of >20 μM. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Medchemexpress LLC ER-27319 maleate | 1204480-26-1 | 99.4% | 396.44 | 100 MG
ER-27319 maleate is an acridone derivative, a potent and selective SYK inhibitor that inhibits the tyrosine phosphorylation of SYK and its activity. It inhibits the release of antigen-induced allergic mediators from human and rat mast cells with an IC50 of 10 μM, making it suitable for the study of allergic diseases.
- Inhibits antigen-induced generation of inositol phosphates
- Inhibits release of arachidonic acid
- Inhibits secretion of histamine and tumor necrosis factor α
- Selectively inhibits the tyrosine phosphorylation of SYK
Sigma Aldrich Fine Chemicals Biosciences Iodoacetamide | 144-48-9 | MFCD00008028 | 25g
Iodoacetamide | Purity: 99% | Mol Wt: 184.96 | 144-48-9 | MFCD00008028 | 25g
Medchemexpress LLC Tegaserod (maleate) | 189188-57-6 | 99.9% | C20H27N5O5 | 1 ML
Tegaserod maleate is an orally active serotonin receptor 4 (HTR4) agonist and a 5-HT2B receptor antagonist. It demonstrates anti-tumor activity by inducing tumor cell apoptosis and blunting PI3K/Akt/mTOR signaling. It is also being researched for its potential in treating irritable bowel syndrome (IBS) and diabetic gastropathy.
- Potent agonist of 5-HT4 receptor
- Antagonist of 5-HT2B receptor
- Induces tumor cell apoptosis
- Blunts PI3K/Akt/mTOR signaling
- Decreases S6 phosphorylation
- Accelerates gastric emptying rate